Bone marrow cell-mediated cardiovascular repair: potential of combined therapies

Trends in Molecular Medicine

Volumn 13, Issue 7, 2007, Pages 278-286

  Napoli, Claudio ^a   Maione, Ciro ^a   Schiano, Concetta ^a   Fiorito, Carmela ^a   Ignarro, Louis J ^b  

^a Excellence Research Center on Cardiovascular Diseases   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOPOIETIN 1; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BERAPROST; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; NITRIC OXIDE; OXYGEN RADICAL; SOMATOMEDIN C; THYMOSIN BETA4; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN; VASCULOTROPIN C; VERY LATE ACTIVATION ANTIGEN 4;

ACUTE HEART INFARCTION; ANGIOGENESIS; ARTERY DISEASE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BIOLOGICAL THERAPY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CLINICAL TRIAL; GENE THERAPY; HUMAN; LIMB ISCHEMIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OXIDATIVE STRESS; STEM CELL MOBILIZATION; TREATMENT RESPONSE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; MODELS, BIOLOGICAL; PERIPHERAL VASCULAR DISEASES; REGENERATION; STEM CELLS; WOUND HEALING;

EID: 34347406145     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2007.05.004     Document Type: Article

References (93)

1. de Nigris F., et al. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol. Med. 9 (2003) 351-359
2. Karra R., et al. Molecular evidence for arterial repair in atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16789-16794
3. McGill Jr. H.C., and McMahan C.A. Determinants of atherosclerosis in the young. Pathobiological determinants of atherosclerosis in youth (PDAY) research group. Am. J. Cardiol. 82 (1998) 30T-36T
4. Napoli C., et al. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet 354 (1999) 1234-1241
5. Napoli C., et al. Fatty streak formation occurs in human fetal aortas and is greatly anhanced by maternal hypercholesterolaemia. Intimal accumulation of low-density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100 (1997) 2680-2690
6. Heil M., et al. Arteriogenesis versus angiogenesis: similarities and differences. J. Cell. Mol. Med. 10 (2006) 45-55
7. Silvestre J.S., et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 87 (2000) 448-452
8. Werner N., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1567-1572
9. Napoli C., et al. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17202-17206
10. de Nigris F., et al. Therapeutical effects of concurrent autologous bone marrow cell infusion and metabolic intervention in ischemia-induced angiogenesis in the hypercholesterolemic mouse hindlimb. Int. J. Cardiol. 117 (2006) 238-243
11. Jiang W., et al. Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch. 453 (2006) 43-52
12. Eglitis M.A., et al. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4080-4085
13. Zhao L.R., et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174 (2002) 11-20
14. Petersen B.E., et al. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
15. Takahashi T., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 (1999) 434-438
16. Ferrari G., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
17. Kawamoto A., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107 (2003) 461-468
18. Li L., et al. Finding the hematopoietic stem cell niche in the placenta. Dev. Cell 8 (2005) 297-298
19. Jin H., et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J. Clin. Invest. 116 (2006) 652-662
20. Jin D.K., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat. Med. 12 (2006) 557-567
21. Petit I., et al. Atypical PKC-zeta regulates SDF-1-mediated migration and development on human CD34+ progenitor cells. J. Clin. Invest. 115 (2005) 168-176
22. Goichberg P., et al. cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors. Blood 107 (2006) 870-879
23. Gnecchi M., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20 (2006) 661-669
24. Bock-Marquette I., et al. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432 (2004) 466-472
25. Grant D.S., et al. Thymosin β4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3 (1999) 125-135
26. Kiel M.J., et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
27. Cancelas J.A., et al. Stem cell mobilization by beta2-agonists. Nat. Med. 12 (2006) 278-279
28. Kopp H.G., et al. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 20 (2005) 349-356
29. Adams G.B., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439 (2006) 599-603
30. Dar A., et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat. Immunol. 6 (2005) 1038-1046
31. Cancelas J.A., et al. Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat. Med. 11 (2005) 886-891
32. Kortesidis A., et al. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105 (2005) 3793-3801
33. Katayama Y., et al. PSGL-1 participares in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 102 (2003) 2060-2067
34. Petit I., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR-4. Nat. Immunol. 3 (2002) 687-694
35. Marinissen M.J., et al. Small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signalling axis. Mol. Cell 14 (2004) 29-41
36. Fukuda T., et al. PINCH-1 is an obligate partner of integrin linked kinase (ILK) functioning in cell shape modulation, motility and survival. J. Biol. Chem. 278 (2003) 51324-51333
37. Troussard A.A., et al. Conditional knock-out of integrin-linked kinase dimostrates an essential role in protein kinase B/Akt activation. J. Biol. Chem. 278 (2003) 22374-22378
38. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
39. Baker A.H., et al. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors,and metabolic treatment in cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3597-3602
40. Yau T.M., et al. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 112 Suppl. 9 (2005) I123-I128
41. Yau T.M., et al. Enhanced angiogenesis with multimodal cell-based gene therapy. Ann. Thorac. Surg. 83 (2007) 1110-1119
42. Kobayashi K., et al. Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1465-1472
43. Kawamoto A., et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110 (2004) 1398-1405
44. LaBarge M.A., et al. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111 (2002) 589-601
45. Korbling M., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheralblood stem cells. N. Engl. J. Med. 346 (2002) 738-746
46. Terada N., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
47. Shintani S., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103 (2001) 897-903
48. Tateishi-Yuyama E., et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells: a pilot study and a randomized controlled trial. Lancet 360 (2002) 427-435
49. Miranville A., et al. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110 (2004) 349-355
50. Choi Y.S., et al. Adipogenic differentiation of adipose tissue derived adult stem cells in nude mouse. Biochem. Biophys. Res. Commun. 345 (2006) 631-637
51. Napoli C., et al. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8797-8802
52. Ignarro L.J., et al. Nutrition, physical activity and cardiovascular disease: An update. Cardiovasc. Res. 73 (2007) 326-340
53. Otsuka H., et al. The prostacyclin analog beraprost sodium augments the efficacy of therapeutic angiogenesis induced by autologous bone marrow cells. Ann. Vasc. Surg. 20 (2006) 646-652
54. Shintani S., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 897-903
55. Iwase T., et al. Adrenomedullin enhances therapeutic potency of bone marrow transplantation for myocardial infarction in rats. Circulation 111 (2005) 356-362
56. Orlic D., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10344-10349
57. Orlic D., et al. Stem cells for myocardial regeneration. Circ. Res. 91 (2002) 1092-1102
58. Wollert K.C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
59. Kajstura J., et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 96 (2005) 127-137
60. Hendrikx M., et al. Recovery of regional but not global contractile function by the directintramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 114 (2006) I101-I107
61. 121 improves lower-extremity endothelial function and flow reserve. Circulation 104 (2001) 753-755
62. Higashi Y., et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilatation in patients with limb ischemia. Circulation 109 (2004) 1215-1218
63. Perin E.C., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
64. Gao L.R., et al. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. Am. J. Cardiol. 98 (2006) 597-602
65. Schachinger V., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
66. Assmus B., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355 (2006) 1222-1232
67. Meyer G.P., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months'follow up data from the randomized, controlled BOOST (Bone Marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
68. Fernandez-Aviles F., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 95 (2004) 742-748
69. Zohlnhofer D., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. J. Am. Med. Assoc. 295 (2006) 1003-1010
70. Strauer B.E., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J. Am. Coll. Cardiol. 46 (2005) 1651-1658
71. Yaoita H., et al. Scintigraphic assessment of the effects of bone marrow-derived mononuclear cell transplantation combined with off-pump coronary artery bypass surgery in patients with ischemic heart disease. J. Nucl. Med. 46 (2005) 1610-1617
72. Assmus B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
73. Janssens S., et al. Autologous bone marrow derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2005) 113-121
74. Chen S.L., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94 (2004) 92-95
75. Cleland J.G., et al. Clinical trials update from the American Association: REPAIR-AMI, ASTAMI, JELIS. MEGA, REVIVE-2, SURVIVE, and PROACTIVE. Eur. J. Heart Fail. 8 (2006) 105-110
76. Lunde K., et al. Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomised controlled trial: intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand. Cardiovasc. J. 39 (2005) 150-158
77. Strauer B.E., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cells transplantation in humans. Circulation 106 (2002) 1913-1918
78. Fuchs S., et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary arthery disease: a feasibility study. J. Am. Coll. Cardiol. 41 (2003) 1721-1724
79. Casamassimi A., et al. Comparison between total endothelial progenitor cell isolation versus enriched CD133+ culture. J. Biochem. (Tokyo) 141 (2007) 503-511
80. Katritsis D.G., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter. Cardiovasc. Interv. 65 (2005) 321-329
81. Goussetis E., et al. Intracoronary infusion o CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy (CIC): cell isolation, adherence to the infarcted area and body distribution. Stem Cells 24 (2006) 2279-2283
82. Suuronen E.J., et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissues using CD133+ progenitors expanded from the peripheral blood. Circulation 114 Suppl. 1 (2006) I138-I144
83. Stamm C., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
84. Stamm C., et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac. Cardiovasc. Surg. 52 (2004) 152-158
85. Tse H.-F., et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
86. Perin E.C., et al. Transendocardial, autologous bone marrow cell transplantation for severe chronicf ischaemic heart failure. Circulation 107 (2003) 2294-2302
87. Wollert K.C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 364 (2004) 141-148
88. Li T.S., et al. The safety and feasibility of the local implantation of autologous bone marrow cells for ischaemic heart disease. J. Card. Surg. 18 (2003) S69-S75
89. Strauer B.E., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT study. J. Am. Coll. Cardiol. 46 (2005) 1651-1658
90. Galinanes M., et al. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant. 13 (2004) 7-13
91. Hamano K., et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischaemic heart disease: clinical trial and preliminary results. Jpn. Circ. J. 65 (2001) 845-847
92. Kuethe F., et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int. J. Cardiol. 97 (2004) 123-127
93. Assmus B., et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017